Improved treatment results of children with B-cell non-Hodgkin lymphoma: A report from the Japanese Pediatric Leukemia/Lymphoma Study Group B-NHL03 study-Reference-Cited by-同舟云学术

Improved treatment results of children with B-cell non-Hodgkin lymphoma: A report from the Japanese Pediatric Leukemia/Lymphoma Study Group B-NHL03 study

Published:2014-02-13 Issue:7 Volume:61 Page:1215-1221
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Tsurusawa Masahito¹,Mori Tetsuya²,Kikuchi Akira³,Mitsui Tetsuo⁴,Sunami Shosuke⁵,Kobayashi Ryoji⁶,Takimoto Tetsuya⁷,Saito Akiko⁸,Watanabe Tomoyuki⁹,Fujimoto Junichiro⁷,Nakazawa Atsuko¹⁰,Ohshima Kouichi¹¹,Horibe Keizo⁸,

Affiliation:

1. Advanced Medical Research Center; Aichi Medical University; Aichi Japan

2. Division of Pediatric Oncology; National Center for Child Health and Development; Tokyo Japan

3. Department of Pediatrics; Teikyo University; Tokyo Japan

4. Pediatric Hematology/Oncology; Yamagata University Hospital; Yamagata Japan

5. Department of Pediatrics; Japanese Red Cross Narita Hospital; Chiba Japan

6. Department of Pediatrics; Sapporo Hokuyu Hospital; Sapporo Japan

7. Clinical Research Center; National Center for Child Health and Development; Tokyo Japan

8. Clinical Research Center; National Hospital Organization Nagoya Medical Center; Nagoya Japan

9. Department of Nutrition and Health; Faculty of Psychological and Physical Science; Aichi Gakuin University; Aichi Japan

10. Department of Pathology; National Center for Child Health and Development; Tokyo Japan

11. Department of Pathology; School of Medicine; Kurume University; Kurume Japan

Funder

Ministry of Health, Labor and Welfare of Japan

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology, and Child Health

Reference29 articles.

1. Non-Hodgkin's lymphomas of childhood and adolescence: Results of a treatment stratified for biologic subtypes and stage. A report of the Berlin Frankfurt-Münster Group;Reiter;J Clin Oncol,1995

2. Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: Reports of the Berlin-Frankfurt-Münster Group trial NHL-BFM 90;Reiter;Blood,1999

3. The Société Française d'Oncologie Pédiatrique LMB89 protocol: Highly effective multiagent chemotherapy tailored to the tumor burden and response in 561 unselected children with B-cell lymphomas and L3 leukemia;Patte;Blood,2001

4. Results of the randomized international FAB/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents. It is possible to reduce treatment for the early responding patients;Patte;Blood,2007

5. Results of a randomized international study of high-risk central nervous system B non-Hodgkin lymphoma and B acute lymphoblastic leukemia in children and adolescents;Cairo;Blood,2007

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Large B-cell lymphoma-IRF4+ in children and young people: time to reduce chemotherapy in a rare malignant mature B-cell neoplasm?;Blood Advances;2024-03-18

2. Rituximab-combined anthracycline-free chemotherapy in newly diagnosed paediatric and adolescent patients with non-high-risk aggressive mature B cell lymphoma: protocol for a single-arm, open-label, multicentre, phase II study (the Japan Children’s Cancer Group Multicentre Trial, JPLSG B-NHL-20);BMJ Open;2024-03

3. The effects of genetic polymorphism on toxicity and pharmacokinetics of methotrexate in Egyptian adult patients with leukaemia or lymphoma;Xenobiotica;2024-02-07

4. Rituximab with standard LMB chemotherapy in pediatric high‐risk mature B‐cell non‐Hodgkin lymphoma: A report from the JPLSG B‐NHL14 trial;European Journal of Haematology;2023-12-19

5. Primary central nervous system lymphoma in children - a rare but serious disease with good prognosis from a single center in China;Leukemia & Lymphoma;2023-11-02